Observational studies indicated that lower Hb levels in diabetic nephropathy/DKD were associated with adverse outcomes, including increased risks for progression of kidney disease, cardiovascular morbidity, and mortality [1, 2]. This evidence concerns the gene GSTM1 and diabetic kidney disease.